Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinol Singapore
Singapore, Singaporesinolsg.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Sinol Singapore is the official distributor of Sinol USA's all-natural, capsaicin-based nasal sprays in Singapore. Operated by Grace Cross Pte. Ltd., the company provides fast-acting, clinically proven over-the-counter (OTC) relief for migraines, chronic sinus issues, allergies, and nasal congestion. Its flagship product, Sinol-M, utilizes a unique homeopathic formula containing capsaicin, aloe vera, eucalyptus oil, and rosemary extract to relieve pain and inflammation without the side effects of rebound congestion or drowsiness. Sinol Singapore distributes these products locally through major e-groceries, retail stores, and pharmacies.
- Therapeutic areas
- PulmonologyOtherImmunologyNeurologyInfectious Diseases
- Modalities
- Small moleculeBotanical extractHerbal medicine
- Industry
- Pharma
02
Partnerships
Sinol USA
Beyond the preview
Go deeper on Sinol Singapore.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sinol Singapore.